Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639132/
https://www.ncbi.nlm.nih.gov/pubmed/36332930
http://dx.doi.org/10.1136/jitc-2022-005424corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639132/
https://www.ncbi.nlm.nih.gov/pubmed/36332930
http://dx.doi.org/10.1136/jitc-2022-005424corr1

Ejemplares similares